AGTR1 and neoplasm: Therefore, it is reasonable to believe that ACEIs decreased angiotensin II levels by inhibiting angiotensin-converting enzyme activity, while ARBs inhibited angiogenesis and tumour cell proliferation by suppressing angiotensin II binding to the AT1 receptor to produce antiprostate cancer effects.